Dan Mulreany

Dan Mulreany has over 10 years of experience in business development and operations. Dan began their career in 2005 as a Research Biomedical Engineer at Johns Hopkins University. In 2011, they became an Image Analyst in Oncology and Immunology Pre-Clinical Research at Human Genome Sciences. In 2013, they moved to CEB as a Senior Analyst in Corporate Strategy and Development. In 2016, they interned at Amgen as a Business Development Intern. In 2017, they became a Consultant at Bain & Company. In 2018, they joined BridgeBio as Vice President of Business Development and Operations, and also became a Board Member of the Wharton Health Care Management Alumni Association. In 2021, they were appointed Head of Business Development and Operations at Navire Pharma. Most recently, in 2023, they became Senior Vice President of Business Development and Strategy at Apogee Therapeutics.

Dan Mulreany has a diverse educational background. Dan obtained a Bachelor of Science in Biomedical Engineering and Electrical Engineering from The Johns Hopkins University, followed by a Master of Science in Engineering in Biomedical Engineering from the same institution. After that, they went on to earn an MBA in Healthcare Management and Finance from The Wharton School.